心得安运动激发试验对儿童生长激素缺乏症的诊断价值

郑方圆; 王雪梅; 王新利

doi:10.7499/j.issn.1008-8830.2015.02.015

PDF(1258 KB)

HTML

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (2) : 180-184. DOI: 10.7499/j.issn.1008-8830.2015.02.015

论著·临床研究

心得安运动激发试验对儿童生长激素缺乏症的诊断价值

郑方圆, 王雪梅, 王新利

作者信息 +

Diagnostic value of the propranolol-exercise provocative test for growth hormone deficiency in children

ZHENG Fang-Yuan, WANG Xue-Mei, WANG Xin-Li

Author information +

文章历史 +

摘要

目的探讨心得安运动激发试验对儿童生长激素缺乏症(GHD)的诊断价值.方法选择在2009年1月至2013年3月期间因身材矮小症住院,同时完善胰岛素激发和心得安运动激发两项试验的儿童,共120例,记录激发试验前后静脉血GH值.将激发试验后血GH峰值<10 ng/mL定义为激发阴性,GH峰值≥10 ng/mL定义为激发阳性.将两项激发试验后血GH峰值均<10 ng/mL者诊断为GHD.结果 120例矮小儿童中,诊断为GHD者29例(24.2%).胰岛素激发试验阳性率为48.3%.心得安运动激发试验阳性率为65.8%.两项激发试验的总符合率为62.5%,阳性符合率为79.3%.心得安运动激发后血GH峰值显著高于胰岛素激发试验的GH峰值.胰岛素激发试验血GH峰值多出现在试验后30~60 min,心得安运动激发试验GH峰值多出现在试验后的120 min.心得安运动激发试验未见不良反应发生.结论心得安运动激发试验与胰岛素激发试验对GH的激发结果符合率较高,且比胰岛素激发试验更易刺激GH分泌,临床可考虑同时应用胰岛素激发试验、心得安运动激发试验联合诊断GHD.

Abstract

Objective To assess the diagnostic value of the propranolol-exercise provocative test for growth hormone deficiency (GHD) in children. Methods This study included 120 children who received both the insulin provocative test and the propranolol-exercise provocative test due to short stature between January 2009 and March 2013. Growth hormone (GH) levels in venous blood were measured before and after the provocative test. Peak GH <10 ng/mL was defined as negative stimulation, while peak GH ≥10 ng/mL was defined as positive stimulation. The children whose peak GH levels were <10 ng/ mL after both tests were diagnosed with GHD. Results Twenty-nine (24.2%) of the 120 children with short stature were diagnosed with GHD. The positive rate in the insulin provocative test was 48.3%, versus 65.8% in the propranolol-exercise provocative test. The overall coincidence rate and positive coincidence rate of the two tests were 62.5% and 79.3%, respectively. The peak GH after the propranolol-exercise provocative test was significantly higher than that after the insulin provocative test (P<0.01). Peak GH occurred mostly at 30-60 minutes after the insulin provocative test, while that occurred mostly at 120 minutes after the propranolol-exercise provocative test. No adverse effects were observed in the propranolol-exercise provocative test. Conclusions Coincidence rates in stimulating the secretion of GH are high between the propranolol-exercise provocative test and the insulin provocative test. Compared with the insulin provocative test, the propranolol-exercise provocative test is more likely to stimulate the secretion of GH. GHD can be clinically diagnosed by the insulin provocative test combined with the propranolol-exercise provocative test.

导出引用

郑方圆, 王雪梅, 王新利. 心得安运动激发试验对儿童生长激素缺乏症的诊断价值[J]. 中国当代儿科杂志. 2015, 17(2): 180-184 https://doi.org/10.7499/j.issn.1008-8830.2015.02.015

ZHENG Fang-Yuan, WANG Xue-Mei, WANG Xin-Li. Diagnostic value of the propranolol-exercise provocative test for growth hormone deficiency in children[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(2): 180-184 https://doi.org/10.7499/j.issn.1008-8830.2015.02.015

参考文献

[1] Carrascosa A, Audi L, Fernandez-Cancio M, et al. Growth hormone secretory status evaluated by growth hormone peak after two pharmacological growth hormone release stimuli did not significantly influence the two-year catch-up growth induced by growth hormone therapy in 318 prepubertal short children with idiopathic growth retardation[J]. Horm Res Paediatr, 2011, 75(2): 106-114.
[2] Bohdanowicz-Pawlak A, Szymczak J, Bladowska J, et al. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report[J]. Med Sci Monit, 2006, 12(2): R75-R80.
[3] 颜纯, 王慕逖. 小儿内分泌学[M]. 北京: 人民卫生出版社, 2006: 91-132.
[4] Munoz-Hoyos A, Hubber E, Escames G, et al. Effect of propranolol plus exercise on melatonin and growth hormone levels in children with growth delay.[J]. J Pineal Res, 2001, 30(2): 75-81.
[5] 吴瑾, 向承发, 王栋. 1038例矮小症病因及治疗的研究[J]. 中国妇幼保健, 2008, 23(7): 947-949.
[6] Gasco V, Corneli G, Beccuti G, et al. Retesting the childhood-onset GH-deficient patient[J]. Eur J Endocrinol, 2008, 159 (Suppl 1): S45-S52.
[7] Galluzzi F, Quaranta MR, Salti R, et al. Are IGF-I and IGF-BP3 useful for diagnosing growth hormone deficiency in children of short stature?[J]. J Pediatr Endocrinol Metab, 2010, 23(12): 1273-1279.
[8] Lee HS, Hwang JS. Influence of body mass index on growth hormone responses to classic provocative tests in children with short stature[J]. Neuroendocrinology, 2011, 93(4): 259-264.
[9] Veldhuis JD, Keenan DM. Model-based evaluation of growth hormone secretion[J]. Methods Enzymol, 2012, 514: 231-248.
[10] van Vught AJ, Nieuwenhuizen AG, Gerver WJ, et al. Pharmacological and physiological growth hormone stimulation tests to predict successful GH therapy in children[J]. J Pediatr Endocrinol Metab, 2009, 22(8): 679-694.
[11] Tanaka T. Global situation of growth hormone treatment in growth hormone- deficient children[J]. Horm Res, 1999, 51 (Suppl 3): 75-80.
[12] Friend K, Iranmanesh A, Login IS, et al. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release[J]. Eur J Endocrinol, 1997, 137(4): 377-386.
[13] 谢坚, 吴勇, 刘亚琼, 等. 矮小儿生长激素激发实验中生长激素高峰时间的探讨[J]. 中国医药指南, 2012 (30): 28-29.
[14] 张莉. 儿童生长激素缺乏症药物激发试验的诊断意义及r-hGH的疗效观察[D]. 大连医科大学学位论文, 2009.
[15] Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children[J]. J Clin Endocrinol Metab,1996, 81(9): 3323-3327.